• Slide 1/4: Woman with hands on stomach overlaid with MALTOL SHIELD TM inside stomach imagery
  • Slide 2/4: Main smiling overlaid with ACCRUFeR pill bottle
  • Slide 3/4: Teen girl smiling with arms crossed overlaid with MALTOL SHIELD TM inside stomach imagery
  • Slide 4/4: Woman with arms crossed overlaid with ACCRUFeR pill bottle

Iron They'll Actually Take1

ACCRUFeR® (ferric maltol) has a patented MALTOL SHIELDTM that reduces free iron in the gut, supporting absorption and resulting in unprecedented GI tolerability.2-4

See what sets ACCRUFeR apart

ACCRUFeR® (ferric maltol) is an FDA-approved prescription oral iron for the treatment of iron deficiency in adults and children 10 years of age and older.2

Get patients started on ACCRUFeR for as little as $0 with our Patient Savings Program (copay card).*
*Restrictions apply

pill-bottle-check_0 1

Free Samples of ACCRUFeR

Your patients deserve a tolerable oral iron treatment. Put ACCRUFeR to the test with free 5-day samples for your patients through MySampleCloset.

Request Samples

Unprecedented tolerability

In clinical studies, 4.6% of patients taking ACCRUFeR (n=175) discontinued treatment due to adverse gastrointestinal reactions, compared with 2.5% of patients taking a placebo (n=120).2,7

About ACCRUFeR
Checkmark icon

Clinically proven efficacy

ACCRUFeR achieved FDA approval based on three pivotal studies in patients with chronic inflammation and malabsorption and one study in children aged 10 to <18 years. Among ID/IDA patients taking ACCRUFeR, significant improvements were seen across iron indices, including hemoglobin, ferritin, and TSAT.2,5,6

Established Safety and Efficacy
Shield with red plus in the middle icon

Patented MALTOL SHIELDTM

ACCRUFeR is a non-salt ferric iron uniquely formulated with a MALTOL SHIELDTM that keeps iron intact as it passes through the stomach. This reduces the likelihood of reactive oxygen species (ROS) formation, which minimizes the risk of GI side effects.2-4

Downsides of Oral Iron Salts
Stomach with shield overlay icon

Available at the lowest price possible

We’re committed to making ACCRUFeR accessible for your patients. Eligible patients may pay as little as $0 for ACCRUFeR.

Access and Affordability
Piggy bank icon

About ACCRUFeR

See how ACCRUFeR's MALTOL SHIELDTM helps minimize the risk of gastrointestinal side effects.2-4

Contact Us

Connect with one of our representatives and sign up for updates from Shield Therapeutics.

References:
1. Schmidt C, Ahmad T, Tulassay Z, et al. Ferric maltol therapy for iron deficiency anaemia in patients with inflammatory bowel disease: long-term extension data from a phase 3 study. Aliment Pharmacol Ther. 2016;44(3):259-270. doi:10.1111/apt.13665
2. ACCRUFeR® full prescribing information. Shield Therapeutics, 2025.
3. Stallmach A, Büning C. Ferric maltol (ST10): a novel oral iron supplement for the treatment of iron deficiency anemia in inflammatory bowel disease. Expert Opin Pharmacother. 2015;16(18):2859-2867. doi:10.1517/14656566.2015.1096929
4. European Medicines Agency. Accessed March 17, 2021. https://www.ema.europa.eu/en/documents/variation-report/feraccru-h-c-2733-ii-0010-epar-assessment-report-variation_en.pdf.
5. Gasche C, Ahmad T, Zsolt T, et al. Ferric maltol is effective in correcting iron deficiency anemia in patients with inflammatory bowel disease: results from a phase-3 clinical trial program. Inflamm Bowel Dis. 2015;21:579-588.
6. Pergola PE, Kopyt NP. Oral ferric maltol for the treatment of iron-deficiency anemia in patients with CKD: a randomized trial and open-label extension. Am J Kidney Dis. 2021;78(6):846-
856.e1. doi:10.1053/j.ajkd.2021.03.020
7. Data on file. Shield Therapeutics Inc. 2019